Sartorius (OTCMKTS:SARTF) Short Interest Down 62.7% in July

Sartorius (OTCMKTS:SARTF) saw a large drop in short interest in the month of July. As of July 15th, there was short interest totaling 915 shares, a drop of 62.7% from the June 30th total of 2,451 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days. Approximately 0.0% of the company’s stock are short sold.

Sartorius Stock Performance

OTCMKTS SARTF opened at $212.80 on Monday. Sartorius has a 1-year low of $181.58 and a 1-year high of $227.00. The company has a current ratio of 0.95, a quick ratio of 0.49 and a debt-to-equity ratio of 0.89. The company has a market capitalization of $7.28 billion, a PE ratio of 98.98 and a beta of 0.98. The firm’s fifty day simple moving average is $211.27 and its 200-day simple moving average is $219.86.

About Sartorius

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.